Ignite Creation Date:
2025-12-24 @ 6:40 PM
Ignite Modification Date:
2026-01-05 @ 2:31 AM
Study NCT ID:
NCT04326257
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-07
First Post:
2020-03-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Personalized Immunotherapy in Patients With Recurrent /Metastatic SCCHN That Have Progressed on Prior Immunotherapy
Sponsor:
Dan Zandberg
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Squamous Cell Carcinoma of the Head and Neck | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | RECIST 1.1 | View |
| None | nivolumab | View |
| None | Relatlimab | View |
| None | Ipilimumab | View |
| None | immunotherapy | View |
| None | anti-PD-1 | View |
| None | anti-PD-L1 | View |
| None | recurrent cancer | View |
| None | metastatic cancer | View |
| None | tumor microenvironment analysis | View |
| None | LAG-3 | View |
| None | CTLA-4 | View |